INTRODUCTION
An emerging bacterial disease, bacterial haemorrhagic ascites caused by Pseudomonas plecoglossicida, is posing a threat to cultured ayu Plecoglossus altivelis in Japan (Nakatsugawa & Iida 1996 , Wakabayashi et al. 1996 , Nishimori et al. 2000 . The disease results in high mortality throughout almost the whole rearing period of ayu, particularly since there are no licensed chemotherapeutic agents available. There is a further complication in that application of florfenicol or sulfisozole as a chemotherapy for coldwater disease caused by Flavobacterium psychrophilum (another serious disease in cultured ayu: Wakabayashi et al. 1994 , Iida & Mizokami 1996 is followed by the abrupt emergence of P. plecoglossicida, which results in heavy mortality.
Although bactriophages can theoretically act as therapeutic agents for bacterial infections, the term 'phage therapy' has long been abandoned since the early uncontrolled studies (reviewed by Barrow & Soothill 1997 , Alisky et al. 1998 , Sulakvelidze et al. 2001 . However, since the 1980s, successful results on phage therapy have been reported using various animal models (Smith & Huggins 1982 , 1983 , Soothill 1994 , Merril et al. 1996 , Barrow et al. 1998 ) and in human drugresistant suppurative infections (Slopek et al. 1987 , Alisky et al. 1998 . A recent study demonstrated that phage therapy frees bacteremic mice from vancomycin-resistant Enterococcus faecium (VRE) (Biswas et al. 2002) . Several review papers have also been published (Lederberg 1996 , Barrow & Soothill 1997 , Alisky et al. 1998 , Carlton 1999 , Sulakvelidze et al. 2001 , Summers 2001 . The successful effect of phages in phage therapy has been proven by an increase in phage particles or the presence of phages in survivors, and the death of host bacterial cells. This distinguishes phage treatment from other biological controls such as ). Mortalities of fish receiving PPpW-3, PPpW-4, PPpW-3/W-4, and a control fish receiving no phages were 53.3, 40.0, 20.0 and 93.3%, respectively. Phage (PPpW-3/W-4)-receiving fish also showed high protection against water-borne infection with P. plecoglossicida. In a field trial, when phage (PPpW-3/W-4)-impregnated feed was administered to ayu in a pond where the disease occurred naturally, daily mortality of fish decreased at a constant level (5% d -1 ) to one-third after a 2 wk period. The causal relationship of phages in this phenomenon was verified by the long-lasting appearance of administered phages in the kidneys of the fish, and a disappearance of P. plecoglossicida from apparently healthy fish. Neither phage-resistant organisms nor phageneutralizing antibodies were detected in diseased fish or apparently healthy fish, respectively. These results indicate the potential for phage control of the disease.
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Resale or republication not permitted without written consent of the publisher probiotics (Reid 1999) . Phages, as specific pathogenkillers, are attractive agents for controlling bacterial infections.
A previous report demonstrated that the oral administration of specific phages was effective in treating ayu experimentally infected with Pseudomonas plecoglossicida (Park et al. 2000) . In order to examine the suitability of phage therapy for use in fish culture, further detailed therapeutic effects of P. plecoglossicida phages were examined against experimental and natural infections.
MATERIALS AND METHODS
Phages and bacteria. Two previously isolated strains of anti-Pseudomonas plecoglossicida phages (Park et al. 2000) , small-plaque-forming PPpW-3 (Myoviridae) and large-plaque-forming PPpW-4 (Podoviridae), and a P. plecoglossicida PTH-9802 strain isolated from a diseased specimen of Plecoglossus altivelis were used in this study. All Pseudomonas plecoglossicida isolates from geographically and chronologically different sources exhibited similar sensitivity to phages of either type. The PTH-9802 is highly susceptible to either type of phage, and is highly virulent to ayu, the LD 50 through intramuscular injection being about 10 1 CFU fish -1 . Phages were propagated using semisolid soybean casein digest agar (SCDA, Nissui) including PTH-9802 cells. Phage suspension (10 9 PFU ml -1
) was stored at 4°C until use. Bacteria were sub-cultured at 25°C on SCDA overnight prior to experiments.
In vitro anti-bacterial activity of phages. Ten ml of soybean casein digest broth (SCDB, Eiken) was inoculated with PTH-9802 (4.8 × 10 2 CFU ml -1
) and serially 10-fold-diluted phages (10 6 to 10 -2 PFU ml -1 ), the phages being either PPpW-3, PPpW-4, or a mixture of PPpW-3 and PPpW-4 (PPpW-3/W-4), and then incubated with gentle agitation at 20°C. Every 12 h for up to 96 h incubation, the optical density (OD) was measured using a spectrophotometer. At the termination of each experiment, a loopful of each culture was inoculated onto SCDA and incubated at 25°C overnight; 10 separated colonies were picked from the plate and examined for sensitivity to each phage. The phage concentration in tubes inoculated with phages of 10 6 , 10 -1 , or 10 -2 PFU ml -1 was also determined at 96 h post-incubation by using a double-agar-layer method described previously (Park et al. 2000) .
Phage-neutralizing antibody production in fish. A total of 100 ayu weighing an average of 3.9 g were inoculated with phage mixture (PPpW-3/W-4) either orally or intramuscularly: 50 fish received phageimpregnated pellets orally for 7 successive days, while the other 50 fish were injected 4 times intramuscularly (IM) at 1 wk intervals. Phage doses in oral administration and IM injection were 7.6 × 10 7 PFU fish -1 and 1.7 × 10 8 PFU fish -1 , respectively. Ten fish were bled without an anesthetic at 0, 1, 2, 3 and 4 wk after the first phage inoculation, and individual serum samples were examined for neutralizing antibodies against both phages inoculated using Pseudomonas plecoglossicida PTH-9802 strain as an indicator. Fifty microliters of serially 2-fold-diluted serum were mixed with 50 µl of phage suspension (10 3 PFU ml -1 ), incubated at 25°C for 1 h, and subjected to a PFU assay by the double-agar-layer method. The virus-neutralizing titer of serum is shown as a reciprocal of the highest dilution of serum, which completely inhibited plaque formation.
Phage treatment of infected fish. Oral, water-borne and in situ challenges were carried out.
Oral challenge: Four groups of 30 ayu weighing an average of 2.7 g were fed pellets impregnated with live Pseudomonas plecoglossicida PTH-9802 cells (6.6 × 10 7 CFU fish -1 ) at a feeding rate of 1.5%, based on body weight. Immediately after feeding with the bacterialoaded pellets, 3 of the groups were fed pellets impregnated with either Phage PPpW-3 (3.5 × 10 7 PFU fish ). Group 4 received feed without phages and served as a control. Fish were observed daily in 40 l tanks with a flow-through system (20 ± 1°C) for 2 wk, and the kidneys of dead fish and survivors at the end of the experiment were subjected to bacterial isolation. The isolates were identified with the aid of rabbit anti-P. plecoglossicida serum.
Water-borne challenge: Four groups of 40 ayu (average weight 4.3 g) were used. Two tanks, 1 small (55 l) and 1 large (250 l), were connected with a water circulation system at 20 ± 1°C; 30 fish, the recipients of the bacteria, were first introduced into the large tank, and then 10 fish, the donors of the bacteria, which had been previously IM-injected with Pseudomonas plecoglossicida (6.0 × 10 3 or 1.6 × 10 4 CFU fish -1 ), were placed in the small tank. Phage (PPpW-3/W-4)-impregnated feed was given to fish in the large tank (7.7 × 10 7 PFU fish -1 ) 24 and 72 h after introduction of the donor fish. In another set of tanks (control group), fish in the small tank were similarly injected with the pathogen but fish in the large tank received phagefree feed at 24 and 72 h post-infection. The donor fish were removed from the tank within 24 h of death; 2 trials were conducted.
Natural challenge: Phage therapy was performed in a commercial fish culture pond where severe Pseudomonas plecoglossicida infection prevailed. At the beginning of the experiment, approximately 120 000 fish weighing an average of 20 g were reared in the pond (200 m 3 ) using ground water (water temperature 18°C). An automatic feeding machine was used to feed the fish. Phage (PPpW-3/W-4)-impregnated pellets (10 7 PFU fish -1 ) were given to fish on Days 0, 1, and 8. To examine the phage-intake rate in the kidneys and intestines, 40 live fish were sacrificed 3 h after administration of phage-impregnated feed on Day 0. Thereafter, on Days 1 and 8, live fish samples were collected 1 h before the administration of phage-impregnated feed. Fish (live and dead, n = 40) and water samples on scheduled days (1, 2, 4, 6, 8 and 15) were subjected to isolation of bacteria and phages. To prevent outbreaks of Flavobacterium psychrophilum infection, an antibacterial drug (sulfisozole sodium) was administered for 8 d starting on Day 2 (110 mg kg -1 d -1
). P. plecoglossicida is not sensitive to this drug (Nakatsugawa & Iida 1996) , and all isolates of P. plecoglossicida in the present study were resistant to the agent throughout the experimental period (MBC = 1000 µg ml -1 or higher). Serum samples (n = 20) were collected from live fish on Days -1 (i.e. 1 d before phage administration), 8, and 15 to examine for the presence of phage-neutralizing and P. plecoglossicida-agglutinating antibodies. Agglutination titers of serum were determined using formalin-killed cells of PTH-9802 in a 96-well microtiter plate. P. plecoglossicida isolates obtained from dead fish throughout the experimental period were also tested for their sensitivity to Phages PPpW-3 and PPpW-4.
Statistical analysis. Statistical analysis was performed using a chi-square test; p < 0.01 was considered significant.
RESULTS

In vitro phage activities
Bacterial growth was first observed at 24 h postinoculation (p.i.) in a tube without phages (control), tubes inoculated at lower doses of PPpW-3, and in all tubes at a dose of 10 -2 PFU ml -1 (theoretically phagefree). Thereafter, OD values reached 1.5 or higher at 36 h p.i. in the control, and within 72 h p.i. in tubes with PPpW-3 (Fig. 1) . In the presence of phages, bacterial growth was inhibited in a dose-dependent manner against the number of inoculated phages. Irrespective of the dose of the inoculated phage, anti-bacterial activity of PPpW-3 was not recognized at incubation periods of 48 h or longer, while growth inhibitory activity of PPpW-4 was observed even after 96 h at a dose of 10 6 PFU ml -1 . The highest inhibition was obtained by inoculation of the mixed phages; in particular, when phages were inoculated at a dose of 10 6 PFU ml -1 , no increase in the OD was observed throughout the 96 h incubation period.
No phages were detected in cultures inoculated with phages at 10 -2 PFU ml -1 at 96 h p.i., while phages at high titers (10 8 to 10 10 PFU ml -1 ) were recovered from cultures initially inoculated with phages of 10 6 and 10 -1 PFU ml -1 (Table 1) . Colonies of dominant bacteria obtained from each culture at 96 h p.i. were tested for sensitivity against Phages PPpW-3 or PPpW-4. Some colonies obtained from cultures inoculated with PPpW-3 at 10 1 PFU ml -1 or higher doses were sensitive to PPpW-4 but not to PPpW-3, while all isolates from other cultures were resistant to both phages, except those inoculated at a dose of 10 -2 PFU ml -1 and controls.
Production of phage-neutralizing antibodies
No neutralizing antibodies against Phages PPpW-3 or PPpW-4 were detected in any serum sample obtained from fish inoculated orally or intramuscularly with phages (titer <1:2) throughout the experimental period.
Therapeutic effects of phages
Oral challenge
In the phage therapy experiments, in which Plecoglossus altivelis were challenged orally with Pseudomonas plecoglossicida and then received oral treatment with phages, the cumulative mortality of fish in the control group receiving phage-free feed was 93.3% after 2 wk. A significantly lower mortality was obtained in fish treated with PPpW-3 (53.3%), PPpW-4 (40.0%), and the phage mixture (20.0%) (Fig. 2) . P. plecoglossicida was re-isolated from only 3 kidneys out of 58 survivors at 15 d p.i.
Water-borne challenge
Ayu fish injected intramuscularly with Pseudomonas plecoglossicida as donors (small tank) died 2 to 5 d after the injection. Significantly lower mortalities (26.7% in both trials) were produced in phage-treated groups, in contrast to those (90.0 and 100%) of phage-untreated controls (Fig. 3) . P. plecoglossicida was re-isolated from only 2 kidneys out of 47 survivors at 15 d p.i.
Natural challenge
The results of phage and bacterial isolation in the field trial of phage treatment using a commercial culture facility are shown in Table 2 . For 2 wk prior to phage treatment, fish mortality in the pond was about 18 kg (ca. n = 900) d -1 . When fish and rearing water were examined 1 and 2 d before phage administration, Pseudomonas plecoglossicida was isolated at high rates from both dead fish (82.5 and 97.5%) and apparently healthy fish (27.5 and 39.5%), and P. plecoglossicida-specific phages were not isolated from the kidney of the fish or the rearing water. In the phage-isolation trial performed on Day 0 to examine the intake rate of phages in fish, phages were detected in 90% (n = 40) of the kidneys at 3 h post-phage administration, while phages were detected in the intestines of all fish examined.
Phage detection rates in live (apparently healthy) and dead fish on Days 1 to 15 were 0 to 17.5% (average 7.1%, n = 240) and 7.5 to 92.5% (average 49.2%, n = 238), respectively. When phages were detected in , while that in dead fish was 10 4 PFU g -1 or higher. Phages were also isolated at a maximum 10 3 PFU ml -1 from rearing water after initiation of phage administration to fish. Detection rates of Pseudomonas plecoglossicida from live fish decreased gradually and became undetectable on Days 8 and 15. There were only 2 live fish in which the bacterium was detected at 10 4 CFU g -1 or higher (on Days 2 and 4). P. plecoglossicida was isolated from 52.5 to 82.5% of dead fish (average 70.2%, n = 238), indicating that factors other than P. plecoglossicida infection caused the mortalities. When 10 dead fish were examined quantitatively, the number of P. plecoglossicida in the kidneys ranged from 10 7 to 10 8 CFU g -1
. Out of 17 phage-carrying fish found on Days 1 to 15, only 2 had P. plecoglossicida in their kidneys.
The daily mortality of fish decreased at a constant level (5.0%) from Days 3 to 15, thereafter reaching a steady state at about 6 kg mortality (ca. n = 300) d -1 (Fig. 4) . A total of 90 Pseudomonas plecoglossicida isolates from dead fish on Days -2, -1, 0, 1, 2, 4, 6, 8 and 15 were all sensitive to both PPpW-3 and PPpW-4 phages. Serum samples (n = 60) obtained from live fish on Days -1, 8, and 15 were all negative for phage-neutralizing antibodies (titer <1:2), while agglutinating antibodies against P. plecoglossicida (PTH-9802) were detected in all serum samples (titers ranging from 1:2 to 1:16; Table 3 ).
DISCUSSION
Previously we reported that oral administration of phages (a mixture of PPpW-3 and PPpW-4) was effective in treating experimental infection of Pseudomonas plecoglossicida in ayu (Park et al. 2000) , but it remains unclear as to which phage effectively contributed to this treatment, and as to the therapeutic effect of phages in natural infections. The present in vitro study proved that PPpW-4 inhibited the growth of P. pleco-37 glossicida more effectively than PPpW-3 (Fig. 1) , and a mixture of the 2 phages induced the highest inhibitory activity. This higher effectiveness of PPpW-4 is partly explained by the fact that PPpW-4 was able to inhibit the growth of P. plecoglossicida cells resistant to PPpW-3, indicating that PPpW-4 has a wider host spectrum. Smith & Huggins (1983) indicated that phages with high activity in vitro are more active in vivo. In the present study, the protective effect of PPpW-4 against oral challenge was slightly higher than that of PPpW-3 (Fig. 2) , and the highest protective effect against infection was obtained by administration of the mixed phages. The high protective effect of oral administration of phages (mixture of PPpW-3 and PPpW-4) was also demonstrated against water-borne challenge by bacteria shed from infected fish (Fig. 3) . In order to simulate phage therapeutic activity in natural infections, the effects of introducing phages into a diseased ayu culture pond was investigated, in which anti-Pseudomonas plecoglossicida phages were below detectable levels before the experiment. Phage administration lowered mortality to one-third during the 2 wk period, and approximately 30% of these mortalities were probably due to Flavobacterium psychrophilum infection, as indicated by the characteristic skin ulceration around the lower jaws. For technical reasons, this field trial did not have a control pond which lacked phage treatment. However, the sequence of phage treatment is indicated by the following results. Phages were isolated at a high rate (90%) from the kidneys soon (3 h) after phage administration, and were detected in live fish for a fairly long period (15 d) at an incidence of 7.1% (Table 2) , while P. plecoglossicida disappeared from live fish by Day 8. The constant decrease (5.0%) in daily mortality from Days 3 to 15 (Fig. 4) was roughly parallel to the estimated phagecarrying rate (7.1%) of live fish mentioned above, indicating that the increased daily survival was phagerelated. In our previous study (Park et al. 2000) , orally administered anti-P. plecoglossicida phages disappeared from the kidneys of uninfected ayu within 12 h. The presence of phages at any given time in the internal organs results from in vivo phage-induced bacterial lysis because of the rapid elimination of phages from intact individuals (Geier et al. 1973 , Merril et al. 1996 . Therefore, the present long-lasting detection of phages in the fish and rearing water indicates continuous multiplication of phages in fish infected with P. plecoglossicida. Furthermore, although we had to use a drug (sulfisozole) to prevent mortality arising from F. psychrophilum infection in the present study, the fact that use of an antimicrobial agent invariably induces severe P. plecoglossicida infection suggests that the phage contributed to the marked reduction in fish mortality through P. plecoglossicida infection. Therefore, the current chemotherapy for F. psychrophilum in ayu culture is invaluable only when phage therapy for P. plecoglossicida is practised simultaneously. Phage therapy of F. psychrophilum infection may be an alternative solution.
Phages which do not encounter host cells are fated to disappear quickly from fish tissue (Nakai et al. 1999 , Park et al. 2000 . Therefore, fish from which phages were detected were those in which phages attacked host bacterial cells proliferating in the fish organs, and thus produced detectable levels of progeny. The high prevalence of phages in dead fish suggests that the phages provide little protection against naturally occurring infections when the fish are already in various stages of the disease process. Given that phages appeared in the fish prior to infection or at the terminal stage of infection, they may offer only limited therapeutic value. Based on the results that the bacterial concentration in live fish was 10 3 CFU g -1 or lower with a few exceptions and that phages were detected in the dead fish at high frequency (Table 2) , it is possible that phages only offer protection at an early stage of infection. Higher therapeutic effects of phages found in experimental infections (compared with that in natural infections) possibly resulted from experimentally synchronized inoculation of bacteria and phages. Despite the self-perpetuating nature of phages in the presence of susceptible bacteria, multiple administrations of phages may be required to reduce bacterial populations in fish and water to safe levels during an outbreak of disease. Use of long-term in vivo survival phage mutants, which may be obtained by successive in vivo passages (Merril et al. 1996) , may enhance phage duration in a fish population.
Previous research has noted a number of intrinsic obstacles in phage treatment (Lederberg 1996 , Barrow & Soothill 1997 , Alisky et al. 1998 , Park et al. 2000 , Sulakvelidze et al. 2001 : the narrow host-specificity of phages, which causes complexity in preparation of 38 therapeutic phage strains; the quick appearance of phage-resistant organisms, as during chemotherapy; and the production of phage-neutralizing antibodies in fish, leading to ineffectiveness of repeated phage therapy. However, these were not real obstacles to phage therapy in the present study on Pseudomonas plecoglossicida infection for the following reasons:
(1) P. plecoglossicida is composed of only a single phage type (Park et al. 2000) ; (2) phage-resistant P. plecoglossicida isolates induced in in vitro culture lack virulence to ayu (Park et al. 2000) ; (3) all P. plecoglossicida isolates from dead fish obtained in the present therapy experiments were still susceptible to phages used for treatment; (4) no neutralizing antibodies were detected in ayu that repeatedly received phageimpregnated feed or intramuscular injections of phages, or in fish in the field phage treatment. However, it is unclear if this arose from low immunogenicity of the phages to ayu, or was due to the low doses inoculated into fish (successive 7 d oral administration with 7.6 × 10 7 PFU fish -1 or 4 weekly IM-injections with 1.7 × 10 8 PFU fish -1 ). Considering that the maximum phage concentration in the kidneys of apparently healthy fish was about 10 4 PFU g -1
, such low numbers of phages in the fish would be less immunogenic, indicating the possibility of repeated phage therapy.
Successful phage treatments by oral administration, particularly using an automatic feeding machine, may be of practical value as a route for therapeutic administration of phages to a large number of fish in aquaculture. In addition to successful phage therapy in Pseudomonas plecoglossicida infection of ayu and Lactococcus garvieae infection of the yellowtail Seriola quinqueradiata (Nakai et al. 1999) , our preliminary study suggests that phage treatment is useful in controlling Vibrio splendidus infection (Sugumar et al. 1998) in cultured larvae of the Pacific oyster Crassostrea gigas. Thus, phage therapy may have many applications in the aquaculture field.
